from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1578c/-

LFCtreatmentdescriptionclass of inhibitor

-0.315

Amikacinug/mL Amikacintranslation

-1.856

Cap5-10ug/mL Capreomycintranslation

-0.390

Rox10-50 ug/mL Roxithromycintranslation

0.828

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.126

Rif0.2-5ug/mL Rifampicintranscription

-0.012

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.404

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.828

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.360

CPZ10-50 ug/mL Chlorpromazinerespiration

0.528

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.155

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.053

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.050

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.221

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.657

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.266

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.238

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.090

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.949

KCN5-20 ug/mL Potassium cyaniderespiration

-0.093

NaN30.2-2 mM Sodium aziderespiration

-0.883

Nigericin50 uM Nigericinrespiration

0.102

TRC10-150 ug/mL Triclosanrespiration

1.023

TRZ10-25 ug/mL Thioridazinerespiration

0.339

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.461

menadione6-10 ug/mL Menadionerespiration

-0.466

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.980

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.512

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.682

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.720

NRP_1Non-replicating persistence stage 1dosRassociated

-0.670

Amp0.2mg/mL AmpicillincellWall

-0.024

Cephalexin20-100 ug/mL CephalexincellWall

0.373

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.524

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.281

EMB10-20 ug/mL EthambutolcellWall

-0.059

Eta12-40 ug/mL EthionamidecellWall

-0.425

INH0.2-0.4 ug/mL IsoniazidcellWall

0.237

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.858

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.040

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.852

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.281

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.317

H2O24 mM hydrogen peroxideDNAdamaging

-0.468

Levo10 ug/mL LevofloxacinDNAdamaging

-0.055

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.124

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.011

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.392

UVUV-irradiationDNAdamaging

-0.509

ARP41-4 ug/mL Antitubercular compound ARP4?

0.180

Antimycin12.5-50 ug/mL Antimycin A?

-0.830

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.126

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.405

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.071

PA8240.2-2 ug/mL PA-824?

0.350

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.026

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.030

Verapamil50 uM Verapamil?

-0.593

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.192

methoxatin10-20 ug/mL Methoxatin?